Methylthioadenosine phosphorylase gene deletions are frequently detected by fluorescence in situ hybridization in conventional chondrosarcomas

Cancer Genetics and Cytogenetics
Warren A ChowMarilyn L Slovak

Abstract

Chondrosarcomas are the second most common primary malignant tumor of bone. Chemotherapy for conventional chondrosarcomas is generally ineffective. Methylthioadenosine phosphorylase (MTAP) is a ubiquitous enzyme, essential in the salvage pathway of adenine and in methionine synthesis. MTAP-deficient cells are more susceptible than wild-type cells to pharmacologic inhibitors of de novo purine synthesis. Homozygous deletions of MTAP have been reported in hematologic and solid tumor malignancies. Based on these observations, we investigated the frequency of MTAP deletions in conventional, grade II chondrosarcomas by fluorescence in situ hybridization (FISH) analysis: 23 conventional, grade II chondrosarcoma patient samples from the Cleveland Clinic Foundation were analyzed for MTAP deletions. Nuclei were successfully extracted from 14 of 23 samples (61% evaluable) for FISH analysis: 7 of 14 samples (50%) showed either homozygous or hemizygous deletion of the MTAP gene, 6 of 14 (43%) failed to show deletion, and 1 of 14 (7%) was inconclusive. These findings suggest that approximately one-half of conventional, grade II chondrosarcomas may be preferentially sensitive to pharmacologic inhibitors of de novo purine synthesis. The presen...Continue Reading

References

Jul 5, 1991·Science·M HollsteinC C Harris
Jun 6, 1991·Nature·A J LevineC A Finlay
Jan 15, 1990·International Journal of Cancer. Journal International Du Cancer·M J Bello, J A Rey
Sep 21, 1988·Journal of the National Cancer Institute·J M CowanU Francke
May 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·C J CarreraD A Carson
Feb 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·N KamataniD A Carson
Sep 30, 1982·Biochemical and Biophysical Research Communications·P S Backlund, R A Smith
Jan 1, 1980·Cancer·D J PritchardB E Medley
Jan 14, 1998·International Journal of Cancer. Journal International Du Cancer·Y HoriT Nobori
Jul 4, 1998·European Journal of Radiology·C MasciocchiA Barile
May 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nasser HannaPaul A Bunn

❮ Previous
Next ❯

Citations

Sep 1, 2006·International Orthopaedics·L B RozemanP C W Hogendoorn
Oct 8, 2013·Hematology/oncology Clinics of North America·Jolieke G van OosterwijkJudith V M G Bovée
Feb 9, 2011·Cancer Biology & Therapy·Joseph R BertinoMartin Lubin
Jul 11, 2013·PloS One·Yuwaraj KadariyaWarren D Kruger
Dec 23, 2017·Artificial Cells, Nanomedicine, and Biotechnology·Yanmei ZhongShanming Sun
Jun 5, 2007·Current Opinion in Oncology·Warren A Chow
Jun 6, 2007·The Journal of Biological Chemistry·Indranil BasuVern L Schramm
Oct 17, 2006·Molecular Cancer Therapeutics·Shrikanta ChattopadhyayI David Goldman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Silvia MarcéElias Campo
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Hsuan-Ying HuangChien-Feng Li
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Karolin H HallorFredrik Mertens
© 2022 Meta ULC. All rights reserved